
Mahmoud Fatahi Yar
Examiner (ID: 19180)
| Most Active Art Unit | 2609 |
| Art Unit(s) | 2609, 2604, 2629, 2774, 2674, 2899, 2606 |
| Total Applications | 600 |
| Issued Applications | 471 |
| Pending Applications | 2 |
| Abandoned Applications | 127 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16108499
[patent_doc_number] => 20200206272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => TREATMENT AGENT FOR EPIDERMOLYSIS BULLOSA
[patent_app_type] => utility
[patent_app_number] => 16/624081
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6510
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624081
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/624081 | TREATMENT AGENT FOR EPIDERMOLYSIS BULLOSA | Jun 18, 2018 | Pending |
Array
(
[id] => 14214571
[patent_doc_number] => 20190119670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHOD FOR ISOLATING CELL-TYPE SPECIFIC MRNAS
[patent_app_type] => utility
[patent_app_number] => 16/011460
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/011460 | METHOD FOR ISOLATING CELL-TYPE SPECIFIC MRNAS | Jun 17, 2018 | Abandoned |
Array
(
[id] => 16223022
[patent_doc_number] => 20200248138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERMLINE STEM CELL-LIKE CELLS
[patent_app_type] => utility
[patent_app_number] => 16/619361
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619361 | METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERMLINE STEM CELL-LIKE CELLS | Jun 5, 2018 | Abandoned |
Array
(
[id] => 13865791
[patent_doc_number] => 20190029236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/996045
[patent_app_country] => US
[patent_app_date] => 2018-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996045
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996045 | METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF | May 31, 2018 | Abandoned |
Array
(
[id] => 20400765
[patent_doc_number] => 12490723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Transgenic chicken that expresses a fluorescent protein and SIAT1
[patent_app_type] => utility
[patent_app_number] => 16/617787
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 16
[patent_no_of_words] => 21338
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617787 | Transgenic chicken that expresses a fluorescent protein and SIAT1 | May 30, 2018 | Issued |
Array
(
[id] => 16427674
[patent_doc_number] => 10827731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Method of inactivating the IPK1 gene in corn
[patent_app_type] => utility
[patent_app_number] => 15/990176
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14028
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990176
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990176 | Method of inactivating the IPK1 gene in corn | May 24, 2018 | Issued |
Array
(
[id] => 13444195
[patent_doc_number] => 20180273640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 15/990561
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -106
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990561
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990561 | MODIFIED T LYMPHOCYTES HAVING IMPROVED SPECIFICITY | May 24, 2018 | Abandoned |
Array
(
[id] => 13590651
[patent_doc_number] => 20180346874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHODS OF OBTAINING CELLS FROM HUMAN POSTPARTUM UMBILICAL CORD ARTERIAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 15/988782
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/988782 | METHODS OF OBTAINING CELLS FROM HUMAN POSTPARTUM UMBILICAL CORD ARTERIAL TISSUE | May 23, 2018 | Abandoned |
Array
(
[id] => 16298126
[patent_doc_number] => 20200283849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/616858
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616858
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616858 | METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF | May 23, 2018 | Pending |
Array
(
[id] => 16051223
[patent_doc_number] => 20200187466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => METHOD FOR CONSTRUCTING MOUSE MODEL WITH CONDITIONAL KNOCKOUT OF TMEM30A GENE FROM PANCREATIC BETA CELL, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/615975
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615975 | METHOD FOR CONSTRUCTING MOUSE MODEL WITH CONDITIONAL KNOCKOUT OF TMEM30A GENE FROM PANCREATIC BETA CELL, AND USE THEREOF | May 17, 2018 | Abandoned |
Array
(
[id] => 13423369
[patent_doc_number] => 20180263227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => Rodents with Conditional ACVR1 Mutant Alleles
[patent_app_type] => utility
[patent_app_number] => 15/983743
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15983743
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/983743 | Rodent embryonic stem cell with conditional ACVR1 mutant alleles | May 17, 2018 | Issued |
Array
(
[id] => 15559853
[patent_doc_number] => 20200064338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => MEASURING FREQUENCY OF VARIOUS SUBSETS OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD AS ESTABLISHED BY VARIOUS PATTERNS OF TCR-INDUCED CA2+ SIGNALING
[patent_app_type] => utility
[patent_app_number] => 16/612675
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612675 | MEASURING FREQUENCY OF VARIOUS SUBSETS OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD AS ESTABLISHED BY VARIOUS PATTERNS OF TCR-INDUCED CA2+ SIGNALING | May 13, 2018 | Abandoned |
Array
(
[id] => 13822547
[patent_doc_number] => 20190014758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => HUMANIZED MOUSE MODEL
[patent_app_type] => utility
[patent_app_number] => 15/977933
[patent_app_country] => US
[patent_app_date] => 2018-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15977933
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/977933 | HUMANIZED MOUSE MODEL | May 10, 2018 | Abandoned |
Array
(
[id] => 19366927
[patent_doc_number] => 12058986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
[patent_app_type] => utility
[patent_app_number] => 16/607074
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 23797
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607074 | Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements | Apr 19, 2018 | Issued |
Array
(
[id] => 13584581
[patent_doc_number] => 20180343839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => KNOCK-IN RODENT COMPRISING A MUTATION IN AN ENDOGENOUS CRBN LOCUS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/955073
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955073
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955073 | IMiD screening methods IMiD-sensitive cells with mutant CRBN | Apr 16, 2018 | Issued |
Array
(
[id] => 13479617
[patent_doc_number] => 20180291351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => Recombinant Influenza Viruses for Vaccines and Gene Therapy
[patent_app_type] => utility
[patent_app_number] => 15/942835
[patent_app_country] => US
[patent_app_date] => 2018-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15942835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/942835 | Recombinant Influenza Viruses for Vaccines and Gene Therapy | Apr 1, 2018 | Abandoned |
Array
(
[id] => 15764283
[patent_doc_number] => 20200113159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => TRANSGENIC RAINBOW SHARK
[patent_app_type] => utility
[patent_app_number] => 16/499636
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -72
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/499636 | TRANSGENIC RAINBOW SHARK | Mar 28, 2018 | Abandoned |
Array
(
[id] => 17220178
[patent_doc_number] => 11172658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase
[patent_app_type] => utility
[patent_app_number] => 15/905249
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19582
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905249
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905249 | Porcine animals lacking expression of functional alpha 1, 3 galactosyltransferase | Feb 25, 2018 | Issued |
Array
(
[id] => 18071564
[patent_doc_number] => 11530388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Methods of engineering human induced pluripotent stem cells to produce liver tissue
[patent_app_type] => utility
[patent_app_number] => 16/485771
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 36
[patent_no_of_words] => 28519
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485771
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485771 | Methods of engineering human induced pluripotent stem cells to produce liver tissue | Feb 12, 2018 | Issued |
Array
(
[id] => 15206263
[patent_doc_number] => 20190365818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => GENETICALLY-TAGGED STEM CELL LINES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/483540
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483540 | GENETICALLY-TAGGED STEM CELL LINES AND METHODS OF USE | Feb 8, 2018 | Abandoned |